NCT07526935

Brief Summary

This study is looking at how safe and effective G-POEM, GES and a combination of both are for people with severe stomach problems (gastroparesis) that haven't gotten better with medicine.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
29mo left

Started Mar 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Mar 2025Dec 2028

Study Start

First participant enrolled

March 19, 2025

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 8, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 14, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2028

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

3.8 years

First QC Date

April 8, 2026

Last Update Submit

April 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gastroparesis Symptom Changes

    Monitoring changes in gastroparesis symptom severity as measured by the Gastroparesis Cardinal Symptom Index (GCSI). A 9-item patient reported questionnaire with a rating scale of 0-5 ranging from 0 (none) to 5 (very severe).

    Baseline, Preoperative 3 months, 6 months, 9 months, 12 months

Secondary Outcomes (8)

  • Subjects quality of life

    Baseline, 6 months, 12 months.

  • Weight

    Baseline, 6 months, 12 months

  • BMI

    Baseline, 6 months, 12 months

  • Nutritional Support Status

    Baseline, 6 months, 12 months

  • Gastroparesis-related hospitalizations

    12 month follow-up

  • +3 more secondary outcomes

Study Arms (4)

Control group

ACTIVE COMPARATOR

GES off + Upper Endoscopy

Device: GES + Upper endoscopy

GES only

ACTIVE COMPARATOR

GES on + Upper Endoscopy

Device: GES on + Upper endscopy

G-POEM only

ACTIVE COMPARATOR

GES off + GPOEM

Procedure: GES off + G-POEM

Combination G-POEM and GES

ACTIVE COMPARATOR

GES on + GPOEM

Procedure: GES on + G-POEM

Interventions

Participants will receive implantation of a gastric electrical stimulator (GES) with upper endoscopy (which is routine during GES placement), without undergoing G-POEM. The stimulator will remain off for the first 6 months and will then be turned on for the following 6 months.

Control group

Participants will receive implantation of a gastric electrical stimulator (GES) with upper endoscopy (which is routine during GES placement), without undergoing G-POEM. The stimulator will stay on for the first 6 months and will then be turned off for the following 6 months.

GES only

Participants will receive implantation of a gastric electrical stimulator (GES) with upper endoscopy (which is routine during GES placement) and G-POEM surgery. The stimulator will remain off for the first 6 months and will then be turned on for the following 6 months.

G-POEM only

Participants will receive implantation of a gastric electrical stimulator (GES) with upper endoscopy (which is routine during GES placement) and G-POEM. POEM. The stimulator will stay on for the first 6 months and will then be turned on for the following 6 months.

Combination G-POEM and GES

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients of age 18 years and older
  • Patients must be able to consent
  • Documented diagnosis of refractory GP as determined by the following criteria:
  • Medically refractory GP symptoms for \> 1 year despite treatment with first-line modalities and pharmacotherapies with anti-emetics and prokinetics AND
  • Gastric emptying scintigraphy showing delayed gastric emptying with retention of \>60% at 2h and/or greater than 10% at 4h based on standardized radionuclide solid meal test
  • Preoperative Gastroparesis Cardinal Symptom Index (GCSI) Score
  • A decision to treat patient with surgical therapy of G-POEM and/or electric stimulator

You may not qualify if:

  • Patients with prior surgical intervention for gastroparesis
  • Patients less than 18 years old
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor University Medical Center

Dallas, Texas, 75246, United States

Location

MeSH Terms

Conditions

Gastroparesis

Interventions

GastroscopyPyloromyotomy

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresGastrectomyMyotomy

Study Officials

  • Marc Ward, MD

    Baylor Health Care System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2026

First Posted

April 14, 2026

Study Start

March 19, 2025

Primary Completion (Estimated)

December 30, 2028

Study Completion (Estimated)

December 30, 2028

Last Updated

April 30, 2026

Record last verified: 2026-04

Locations